217 related articles for article (PubMed ID: 20098286)
1. Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection.
Wallia A; Parikh ND; Molitch ME; Mahler E; Tian L; Huang JJ; Levitsky J
Transplantation; 2010 Jan; 89(2):222-6. PubMed ID: 20098286
[TBL] [Abstract][Full Text] [Related]
2. Glycemic control by a glucose management service and infection rates after liver transplantation.
Wallia A; Parikh ND; O'Shea-Mahler E; Schmidt K; DeSantis AJ; Tian L; Levitsky J; Molitch ME
Endocr Pract; 2011; 17(4):546-51. PubMed ID: 21324822
[TBL] [Abstract][Full Text] [Related]
3. Effect of intraoperative hyperglycemia during liver transplantation.
Ammori JB; Sigakis M; Englesbe MJ; O'Reilly M; Pelletier SJ
J Surg Res; 2007 Jun; 140(2):227-33. PubMed ID: 17509267
[TBL] [Abstract][Full Text] [Related]
4. Association of hyperglycemia on allograft function in the early period after renal transplantation.
Ganji MR; Charkhchian M; Hakemi M; Nederi GH; Solymanian T; Saddadi F; Amini M; Najafi I
Transplant Proc; 2007 May; 39(4):852-4. PubMed ID: 17524830
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, Risk Factors, and Impact of Donor-Specific Alloantibodies After Adult Liver Transplantation.
Vandevoorde K; Ducreux S; Bosch A; Guillaud O; Hervieu V; Chambon-Augoyard C; Poinsot D; André P; Scoazec JY; Robinson P; Boillot O; Dubois V; Dumortier J
Liver Transpl; 2018 Aug; 24(8):1091-1100. PubMed ID: 29665189
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil.
D'Avola D; Cuervas-Mons V; Martí J; Ortiz de Urbina J; Lladó L; Jimenez C; Otero E; Suarez F; Rodrigo JM; Gómez MA; Fraga E; Lopez P; Serrano MT; Rios A; Fábrega E; Herrero JI
Liver Transpl; 2017 Apr; 23(4):498-509. PubMed ID: 28160394
[TBL] [Abstract][Full Text] [Related]
7. Impact of Perioperative Massive Transfusion on Long Term Outcomes of Liver Transplantation: a Retrospective Cohort Study.
Tan L; Wei X; Yue J; Yang Y; Zhang W; Zhu T
Int J Med Sci; 2021; 18(16):3780-3787. PubMed ID: 34790053
[No Abstract] [Full Text] [Related]
8. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
[TBL] [Abstract][Full Text] [Related]
10. Effects of hyperglycemia on the development of new-onset diabetes after liver transplantation.
Anderson AL; Lewis DA; Steinke DT; Ranjan D; Smith KM; Clifford TM
Prog Transplant; 2009 Dec; 19(4):298-303. PubMed ID: 20050451
[TBL] [Abstract][Full Text] [Related]
11. The impact of post-transplant diabetes mellitus on liver transplant outcomes.
Lieber SR; Lee RA; Jiang Y; Reuter C; Watkins R; Szempruch K; Gerber DA; Desai CS; DeCherney GS; Barritt AS
Clin Transplant; 2019 Jun; 33(6):e13554. PubMed ID: 30927288
[TBL] [Abstract][Full Text] [Related]
12. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation.
Park C; Hsu C; Neelakanta G; Nourmand H; Braunfeld M; Wray C; Steadman RH; Hu KQ; Cheng RT; Xia VW
Transplantation; 2009 Apr; 87(7):1031-6. PubMed ID: 19352123
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation.
Aravinthan AD; Fateen W; Doyle AC; Venkatachalapathy SV; Issachar A; Galvin Z; Sapisochin G; Cattral MS; Ghanekar A; McGilvray ID; Selzner M; Grant DR; Selzner N; Lilly LB; Renner EL; Bhat M
Transplantation; 2019 Dec; 103(12):2523-2530. PubMed ID: 30985734
[TBL] [Abstract][Full Text] [Related]
14. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
Jain A; Mazariegos G; Kashyap R; Green M; Gronsky C; Starzl TE; Fung J; Reyes J
Transplantation; 2000 Aug; 70(4):617-25. PubMed ID: 10972220
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes of Simultaneous Liver-Kidney Transplant Patients with Hepatitis B Compared to with Liver Transplant Alone.
Li H; Fan MQ; Men TY; Wang YP; Xing TH; Fan JW; Peng ZH; Zhong L
Med Sci Monit; 2016 Feb; 22():332-40. PubMed ID: 26828767
[TBL] [Abstract][Full Text] [Related]
16. Predictive roles of intraoperative blood glucose for post-transplant outcomes in liver transplantation.
Park CS
World J Gastroenterol; 2015 Jun; 21(22):6835-41. PubMed ID: 26078559
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
Rich N; Tanriover B; Singal AG; Marrero JA
Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759
[TBL] [Abstract][Full Text] [Related]
18. New-onset hyperglycemia immediately after liver transplantation: A national survey from China Liver Transplant Registry.
Ke QH; Huang HT; Ling Q; Liu JM; Dong SY; He XX; Zhang WJ; Zheng SS
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):310-315. PubMed ID: 30108018
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
20. Impact of Rifaximin Therapy on Ischemia/Reperfusion Injury in Liver Transplantation: A Propensity Score-Matched Analysis.
Ito T; Nakamura K; Kageyama S; Korayem IM; Hirao H; Kadono K; Aziz J; Younan S; DiNorcia J; Agopian VG; Yersiz H; Farmer DG; Busuttil RW; Kupiec-Weglinski JW; Kaldas FM
Liver Transpl; 2019 Dec; 25(12):1778-1789. PubMed ID: 31509643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
